Subscribe To

Price Alert Latest News Economic Calendar News

SGFY / Checking Signify Health Before The CVS Transaction

The planned CVS acquisition of SGFY is just around the corner, stated for completion in H1 FY23. SGFY is well positioned to hit top-bottom line growth targets; therefore, there's good accretion potential for its new acquirer. Read More

Demo Live Account See Partner Details

Content Topics

Checking

Signify

Health

Before

Transaction

Stock

SGFY

Posted: Dec 21 2022, 16:02

Author Name: Seeking Alpha

SGFY News

By Zacks Investment Research
March 28, 2023

Strength Seen in Signify (SGFY): Can Its 5.8% Jump Turn into More Strength?

Signify (SGFY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the s

By The Motley Fool
March 24, 2023

This Boring Business Could Be a Secret Weapon to Beat the Market

CVS has piled on debt to reinvent its business. The stock's been sold off in this high-interest-rate environment.

By 24/7 Wall Street
March 20, 2023

These Are the Top 10 Holdings of George Soros

George Soros is considered to be among the most successful investors of all time. He managed client money from 1969 to 2011 and his Quantum Fund gave

By InvestorPlace
March 13, 2023

3 Growth Stocks That Could Disrupt the Healthcare Industry

Healthcare growth stocks are often sought out by investors looking for market disruptors. That's because these stocks can potentially deliver high r

By Seeking Alpha
December 21, 2022

Checking Signify Health Before The CVS Transaction

The planned CVS acquisition of SGFY is just around the corner, stated for completion in H1 FY23. SGFY is well positioned to hit top-bottom line growth

By Pulse2
September 6, 2022

Why CVS Health (CVS) Is Buying Signify Health (SGFY) For About $8 Billion

CVS Health (NYSE: CVS) is buying Signify Health (NYSE: SGFY) for about $8 billion. This is why.

By PYMNTS
September 6, 2022

Deal! CVS Wins $8B Bid for Signify Health

CVS emerged as the winner and closed an $8 billion deal in a hotly contested bid to acquire value-based healthcare solutions platform Signify Health,

By Finbold
September 6, 2022

CVS Health to acquire Signify Health in an $8 billion deal, or $30.50 per share

On September 5, CVS Health (NYSE: CVS) agreed to acquire Signify Health (NYSE: SGFY) for $30.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.